1. Cell Biology

Mitochondria: Selective protein degradation ensures cellular longevity

https://doi.org/10.7554/eLife.17185
  • Download
  • Cite
  • CommentOpen annotations (there are currently 0 annotations on this page).
Share this article
Cite this article
  1. Sandra Malmgren Hill
  2. Thomas Nyström
(2016)
Mitochondria: Selective protein degradation ensures cellular longevity
eLife 5:e17185.
https://doi.org/10.7554/eLife.17185
  2. Download BibTeX
  3. Download .RIS
  1. Sandra Malmgren Hill
  2. Thomas Nyström  Is a corresponding author
  1. University of Gothenburg, Sweden

Mitochondria provide cells with energy and metabolite molecules that are essential for cell growth, and faulty mitochondria cause a number of severe genetic and age-related diseases, including Friedreich's ataxia, diabetes and cancer (Held and Houtkooper, 2015; Suliman and Piantadosi, 2016). To maintain mitochondria in a fully working state, cells have evolved a range of quality control systems for them (Held and Houtkooper, 2015). For example, faulty mitochondria can be removed through a process called mitophagy. In this process, which is similar to autophagy (the process used by cells to degrade unwanted proteins and organelles), the entire mitochondrion is enclosed by a double membrane. In yeast cells this structure fuses with a compartment called the vacuole, where various enzymes degrade and destroy the mitochondrion (Youle and Narendra, 2011). In animal cells an organelle called the lysosome takes the place of the vacuole.

Now, in eLife, Adam Hughes, Daniel Gottschling and colleagues at the Fred Hutchinson Cancer Research Center and University of Utah School of Medicine report evidence for a new quality control mechanism that helps to protect mitochondria from age- and stress-related damage in yeast (Hughes et al., 2016). In this mechanism, a mitochondrion can selectively remove part of its membrane to send the proteins embedded in this region to the lysosome/vacuole to be destroyed, while leaving the remainder of the mitochondrion intact (Figure 1).

Figure 1
Download asset Open asset
Degradation of mitochondria and selected mitochondrial membrane proteins.

Yeast cells respond to stress and aging by sending a specific set of mitochondrial membrane proteins into the vacuole for degradation (top). This pathway involves the formation of a mitochondrial …

Hughes et al. tracked the fate of Tom70, a protein that is found in the outer membrane of mitochondria, and discovered that it accumulated in the vacuole as the yeast aged. This accumulation was not the result of mitophagy, as Tom70 was directed to the vacuole even when a gene required for mitophagy was absent. Previous reports have linked cellular aging to a decline in mitochondrial activity (McMurray and Gottschling, 2003), which is caused by an earlier loss of pH control in the vacuole (Hughes and Gottschling, 2012). For this reason, Hughes et al. tested whether a drug that disrupts the pH of the vacuole triggers the degradation of Tom70. This appears to be the case – the drug caused Tom70 to move from the mitochondria to the vacuole for degradation.

Before Tom70 ended up in the vacuole it accumulated in a mitochondrial-derived compartment (MDC) at the surface of the mitochondria, close to the membrane of the vacuole. The formation of this compartment depended on the machinery that drives the process by which mitochondria divide. However, the subsequent delivery of the contents of the MDC to the vacuole used factors that are required for the late stages of autophagy (Figure 1).

Hughes et al. found that the MDC contained Tom70 and 25 other proteins, all of which are mitochondrial membrane proteins that rely on Tom70 to import them into the mitochondrial membrane. This suggests that the MDC degradation pathway selectively removes a specific group of mitochondrial proteins. An obvious question, therefore, is: how and why does disrupting the ability of the vacuole to control its pH trigger the selective delivery and degradation of these proteins?

Hughes et al. hypothesize that MDC formation is linked to metabolite imbalance, as the loss of acidity inside the vacuole prevents amino acids from being stored there (Klionsky et al., 1990). This in turn leads to a build up of amino acids in the cytoplasm that can overburden the transport proteins that import them into the mitochondria (Hughes and Gottschling, 2012). In this scenario, the selective degradation of mitochondrial transport proteins by the MDC pathway can be seen as a response that protects the organelle against an unregulated, and potentially harmful, influx of amino acids.

While MDCs still formed in very old yeast cells, they remained in vesicle-like structures in the cytoplasm and were not delivered to the vacuole. It therefore appears possible that the accumulation of undegradable cytosolic MDCs in the cytoplasm can contribute to the decline of the aging cell, much like the accumulation of protein aggregates does (Nystrom and Liu, 2014; Hill et al., 2014).

The discovery of MDCs and their role in delivering specific mitochondrial proteins to the vacuole for degradation raises a number of questions that may shed further light on both this process and the trials of aging. Do the MDCs contain regulatory factors that are required for delivering proteins into the vacuole? Why do MDCs fail to be delivered into the vacuole in old cells? The degradative enzymes inside the vacuole do not work well under conditions of elevated pH. It will therefore also be important to learn how long the degradation of mitochondrial membrane proteins can be maintained under these conditions (Kane, 2006).

References

    1. Klionsky DJ
    2. Herman PK
    3. Emr SD
    (1990)
    The fungal vacuole: composition, function, and biogenesis
    Microbiological Reviews 54:266–292.
    1. Youle RJ
    2. Narendra DP
    (2011) Mechanisms of mitophagy
    Nature Reviews Molecular Cell Biology 12:9–14.
    https://doi.org/10.1038/nrm3028

Article and author information

Author details

  1. Sandra Malmgren Hill

    Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7969-097X

  2. Thomas Nyström

    Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
    For correspondence
    thomas.nystrom@cmb.gu.se
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5489-2903

Publication history

  1. Version of Record published:

Copyright

© 2016, Malmgren Hill et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Download links

Categories and tags

Research organism

    1. Related to

    Selective sorting and destruction of mitochondrial membrane proteins in aged yeast

    Adam L Hughes, Casey E Hughes ... Daniel E Gottschling
  2. Further reading

Further reading

    1. Cell Biology

    Selective sorting and destruction of mitochondrial membrane proteins in aged yeast

    Adam L Hughes, Casey E Hughes ... Daniel E Gottschling
    Research Article Updated

    Mitochondrial dysfunction is a hallmark of aging, and underlies the development of many diseases. Cells maintain mitochondrial homeostasis through a number of pathways that remodel the mitochondrial proteome or alter mitochondrial content during times of stress or metabolic adaptation. Here, using yeast as a model system, we identify a new mitochondrial degradation system that remodels the mitochondrial proteome of aged cells. Unlike many common mitochondrial degradation pathways, this system selectively removes a subset of membrane proteins from the mitochondrial inner and outer membranes, while leaving the remainder of the organelle intact. Selective removal of preexisting proteins is achieved by sorting into a mitochondrial-derived compartment, or MDC, followed by release through mitochondrial fission and elimination by autophagy. Formation of MDCs requires the import receptors Tom70/71, and failure to form these structures exacerbates preexisting mitochondrial dysfunction, suggesting that the MDC pathway provides protection to mitochondria in times of stress.

    1. Cell Biology

    Small-molecule activation of TFEB alleviates Niemann–Pick disease type C via promoting lysosomal exocytosis and biogenesis

    Kaili Du, Hongyu Chen ... Dan Li
    Research Article

    Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.

    1. Cell Biology

    Stratification of enterochromaffin cells by single-cell expression analysis

    Yan Song, Linda J Fothergill ... Gene W Yeo
    Research Article

    Dynamic interactions between gut mucosal cells and the external environment are essential to maintain gut homeostasis. Enterochromaffin (EC) cells transduce both chemical and mechanical signals and produce 5-hydroxytryptamine to mediate disparate physiological responses. However, the molecular and cellular basis for functional diversity of ECs remains to be adequately defined. Here, we integrated single-cell transcriptomics with spatial image analysis to identify 14 EC clusters that are topographically organized along the gut. Subtypes predicted to be sensitive to the chemical environment and mechanical forces were identified that express distinct transcription factors and hormones. A Piezo2+ population in the distal colon was endowed with a distinctive neuronal signature. Using a combination of genetic, chemogenetic, and pharmacological approaches, we demonstrated Piezo2+ ECs are required for normal colon motility. Our study constructs a molecular map for ECs and offers a framework for deconvoluting EC cells with pleiotropic functions.